These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 23774623

  • 1. Inhibitory effects of caspase inhibitors on the activity of matrix metalloproteinase-2.
    Castro MM, Fuah J, Ali M, Sung M, Schulz J, Kondo MY, Fan X, Holt A, Schulz R.
    Biochem Pharmacol; 2013 Aug 15; 86(4):469-75. PubMed ID: 23774623
    [Abstract] [Full Text] [Related]

  • 2. Calpain inhibitors exhibit matrix metalloproteinase-2 inhibitory activity.
    Ali MA, Stepanko A, Fan X, Holt A, Schulz R.
    Biochem Biophys Res Commun; 2012 Jun 22; 423(1):1-5. PubMed ID: 22575511
    [Abstract] [Full Text] [Related]

  • 3. Doxorubicin induces de novo expression of N-terminal-truncated matrix metalloproteinase-2 in cardiac myocytes.
    Chan BYH, Roczkowsky A, Moser N, Poirier M, Hughes BG, Ilarraza R, Schulz R.
    Can J Physiol Pharmacol; 2018 Dec 22; 96(12):1238-1245. PubMed ID: 30308129
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of caspase-3 improves contractile recovery of stunned myocardium, independent of apoptosis-inhibitory effects.
    Ruetten H, Badorff C, Ihling C, Zeiher AM, Dimmeler S.
    J Am Coll Cardiol; 2001 Dec 22; 38(7):2063-70. PubMed ID: 11738316
    [Abstract] [Full Text] [Related]

  • 5. Junctophilin-2 is a target of matrix metalloproteinase-2 in myocardial ischemia-reperfusion injury.
    Chan BYH, Roczkowsky A, Cho WJ, Poirier M, Lee TYT, Mahmud Z, Schulz R.
    Basic Res Cardiol; 2019 Sep 10; 114(6):42. PubMed ID: 31506724
    [Abstract] [Full Text] [Related]

  • 6. Myocardial MMP-2 contributes to SERCA2a proteolysis during cardiac ischaemia-reperfusion injury.
    Roczkowsky A, Chan BYH, Lee TYT, Mahmud Z, Hartley B, Julien O, Armanious G, Young HS, Schulz R.
    Cardiovasc Res; 2020 Apr 01; 116(5):1021-1031. PubMed ID: 31373602
    [Abstract] [Full Text] [Related]

  • 7. Hydrogen peroxide-induced necrotic cell death in cardiomyocytes is independent of matrix metalloproteinase-2.
    Ali MA, Kandasamy AD, Fan X, Schulz R.
    Toxicol In Vitro; 2013 Sep 01; 27(6):1686-92. PubMed ID: 23665313
    [Abstract] [Full Text] [Related]

  • 8. Hepatic ischemia/reperfusion injury is prevented by a novel matrix metalloproteinase inhibitor, ONO-4817.
    Shirahane K, Yamaguchi K, Koga K, Watanabe M, Kuroki S, Tanaka M.
    Surgery; 2006 May 01; 139(5):653-64. PubMed ID: 16701099
    [Abstract] [Full Text] [Related]

  • 9. Caspase inhibition and limitation of myocardial infarct size: protection against lethal reperfusion injury.
    Mocanu MM, Baxter GF, Yellon DM.
    Br J Pharmacol; 2000 May 01; 130(2):197-200. PubMed ID: 10807653
    [Abstract] [Full Text] [Related]

  • 10. Induction of caspase-mediated cell death by matrix metalloproteinases in cerebral endothelial cells after hypoxia-reoxygenation.
    Lee SR, Lo EH.
    J Cereb Blood Flow Metab; 2004 Jul 01; 24(7):720-7. PubMed ID: 15241180
    [Abstract] [Full Text] [Related]

  • 11. Matrix metalloproteinase-2 in oncostatin M-induced sarcomere degeneration in cardiomyocytes.
    Fan X, Hughes BG, Ali MA, Chan BY, Launier K, Schulz R.
    Am J Physiol Heart Circ Physiol; 2016 Jul 01; 311(1):H183-9. PubMed ID: 27199120
    [Abstract] [Full Text] [Related]

  • 12. Effect of hydroxamic acid-based matrix metalloproteinase inhibitors on human gingival cells and Porphyromonas gingivalis.
    Yoshioka M, Yokoyama N, Masuda K, Honna T, Hinode D, Nakamura R, Rouabhia M, Mayrand D, Grenier D.
    J Periodontol; 2003 Aug 01; 74(8):1219-24. PubMed ID: 14514237
    [Abstract] [Full Text] [Related]

  • 13. Caspase activation and mitochondrial cytochrome C release during hypoxia-mediated apoptosis of adult ventricular myocytes.
    de Moissac D, Gurevich RM, Zheng H, Singal PK, Kirshenbaum LA.
    J Mol Cell Cardiol; 2000 Jan 01; 32(1):53-63. PubMed ID: 10652190
    [Abstract] [Full Text] [Related]

  • 14. MMP inhibitors attenuate doxorubicin cardiotoxicity by preventing intracellular and extracellular matrix remodelling.
    Chan BYH, Roczkowsky A, Cho WJ, Poirier M, Sergi C, Keschrumrus V, Churko JM, Granzier H, Schulz R.
    Cardiovasc Res; 2021 Jan 01; 117(1):188-200. PubMed ID: 31995179
    [Abstract] [Full Text] [Related]

  • 15. Postresuscitation administration of doxycycline preserves cardiac contractile function in hypoxia-reoxygenation injury of newborn piglets*.
    LaBossiere JR, Pelletier JS, Ali MA, Thiesen A, Schulz R, Bigam DL, Cheung PY.
    Crit Care Med; 2014 Apr 01; 42(4):e260-9. PubMed ID: 24335448
    [Abstract] [Full Text] [Related]

  • 16. Degradation of cardiac myosin light chain kinase by matrix metalloproteinase-2 contributes to myocardial contractile dysfunction during ischemia/reperfusion.
    Gao L, Zheng YJ, Gu SS, Tan JL, Paul C, Wang YG, Yang HT.
    J Mol Cell Cardiol; 2014 Dec 01; 77():102-12. PubMed ID: 25451385
    [Abstract] [Full Text] [Related]

  • 17. Titin is a target of matrix metalloproteinase-2: implications in myocardial ischemia/reperfusion injury.
    Ali MA, Cho WJ, Hudson B, Kassiri Z, Granzier H, Schulz R.
    Circulation; 2010 Nov 16; 122(20):2039-47. PubMed ID: 21041693
    [Abstract] [Full Text] [Related]

  • 18. Mechanisms of cytosolic targeting of matrix metalloproteinase-2.
    Ali MA, Chow AK, Kandasamy AD, Fan X, West LJ, Crawford BD, Simmen T, Schulz R.
    J Cell Physiol; 2012 Oct 16; 227(10):3397-404. PubMed ID: 22212960
    [Abstract] [Full Text] [Related]

  • 19. Matrix metalloproteinase-2 contributes to tumor necrosis factor alpha induced apoptosis in cultured rat cardiac myocytes.
    Shen J, O'Brien D, Xu Y.
    Biochem Biophys Res Commun; 2006 Sep 08; 347(4):1011-20. PubMed ID: 16857167
    [Abstract] [Full Text] [Related]

  • 20. Matrix metalloproteinase-2 (MMP-2) is present in the nucleus of cardiac myocytes and is capable of cleaving poly (ADP-ribose) polymerase (PARP) in vitro.
    Kwan JA, Schulze CJ, Wang W, Leon H, Sariahmetoglu M, Sung M, Sawicka J, Sims DE, Sawicki G, Schulz R.
    FASEB J; 2004 Apr 08; 18(6):690-2. PubMed ID: 14766804
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.